服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-Staphylococcus aureus Toxin A mAbs [Suvratoxumab Biosimilar] (MABL-5270) | MABL-5270 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF13B/CD257/BAFF mAbs [Tabalumab Biosimilar] (MABL-5271) | MABL-5271 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL6 mAbs [Tabirafusp Biosimilar] (MABL-5272) | MABL-5272 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FZD10/CD350 mAbs [Tabituximab Biosimilar] (MABL-5273) | MABL-5273 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Alpha Ferroprotein mAbs [Tacatuzumab Biosimilar] (MABL-5274) | MABL-5274 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ITGA2B and ITGB3 mAbs [Tadocizumab Biosimilar] (MABL-5275) | MABL-5275 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD19 mAbs [Tafasitamab Biosimilar] (MABL-5276) | MABL-5276 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PCSK9 mAbs [Tafolecimab Biosimilar] (MABL-5277) | MABL-5277 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-MUC16/CA125 mAbs [Sofituzumab Biosimilar] (MABL-5239) | MABL-5239 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Solabafusp Biosimilar] (MABL-5240) | MABL-5240 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-APP mAbs [Solanezumab Biosimilar] (MABL-5241) | MABL-5241 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EPCAM/CD326;CD3E mAbs [Solitomab Biosimilar] (MABL-5242) | MABL-5242 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Kappa |
| Anti-VSIR/VISTA/B7H5/PD1H/SISP1 mAbs [Solnerstotug Biosimilar] (MABL-5243) | MABL-5243 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TSLP mAbs [Solrikitug Biosimilar] (MABL-5244) | MABL-5244 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Influenza A HA mAbs [Sonavibart Biosimilar] (MABL-5245) | MABL-5245 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A;ALB mAbs [Sonelokimab1 Biosimilar] (MABL-5246) | MABL-5246 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-IL17F mAbs [Sonelokimab2 Biosimilar] (MABL-5247) | MABL-5247 | ELISA, FACS, Functional assay, in vivo binding | na, na |
| Anti-CLDN18 mAbs [Sonesitatug Biosimilar] (MABL-5248) | MABL-5248 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFR-1 mAbs [Sotiburafusp Biosimilar] (MABL-5249) | MABL-5249 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Sotigalimab Biosimilar] (MABL-5250) | MABL-5250 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn